Drug
Tavilermide clinical trials
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2010 (1)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Mimetogen Pharmaceuticals USA, Inc. (6)
Studies
Open first, then newest update. How each study uses tavilermide is read from its arms, and is right about nine times in ten.
Testing it · 6
- Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry EyeCompletedPhase 3Mimetogen Pharmaceuticals USA, Inc.NCT05848128Written as 5% Tavilermide ophthalmic solution
- Tavilermide Ophthalmic Solution for the Treatment of Dry EyeCompletedPhase 3Mimetogen Pharmaceuticals USA, Inc.NCT03925727Written as Tavilermide ophthalmic solution
- A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry EyeCompletedPhase 3Mimetogen Pharmaceuticals USA, Inc.NCT01960010Written as MIM-D3 Ophthalmic Solution
- Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry EyeCompletedPhase 2Mimetogen Pharmaceuticals USA, Inc.NCT01257607Written as MIM-D3 Ophthalmic Solution
- A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye DiseaseCompletedPhase 3Mimetogen Pharmaceuticals USA, Inc.NCT02665234Written as 1% Tavilermide Ophthalmic Solution
- A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry EyeCompletedPhase 3Mimetogen Pharmaceuticals USA, Inc.NCT02634853Written as 1% Tavilermide Ophthalmic Solution
Codes
What other systems call tavilermide · ClinicalTrials.gg INT017393
- UNII (FDA) NMG938VJ6TTAVILERMIDEConfirmed FDA, Wikidata
- Wikidata Q21098996tavilermideConfirmed FDA, Wikidata
- NCI Thesaurus C174759TavilermideOne source FDA
- DrugBank DB12441One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | NMG938VJ6T | TAVILERMIDE | Confirmed FDA, Wikidata |
| Wikidata | Q21098996 | tavilermide | Confirmed FDA, Wikidata |
| NCI Thesaurus | C174759 | Tavilermide | One source FDA |
| DrugBank | DB12441 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.